MarketInOut Stock Screener Log In | Sign Up
 

United Therapeutics Corp

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/13/2026 11:36
United Therapeutics Corp stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization22,579 mln
Float38.32 mln
Earnings Date11/04/2026

EPS

27.93
Exceptional

P / E

18.15
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.07
Reliable

1-Year Forecast

653
Strong upside

Relative Strength

15 / 100
Significantly lagging

Business Description

United Therapeutics is a pharmaceutical company focused on helping people with serious, long-term illnesses that currently have few good treatment options. The company sells several approved medicines for pulmonary arterial hypertension, a life-threatening condition affecting the lungs and heart, as well as a treatment for a rare childhood cancer. Beyond its existing products, United Therapeutics is working on next-generation drug delivery devices and conducting early-stage research into lab-grown and gene-edited animal organs that could one day be transplanted into humans.

Key Fundamentals

EPS27.93
P/E18.15
ROE19.77
RPS67.27
ROIC27.67
ROA17.68
Interest Cover117
EBITDA, mln1,676
EV / EBITDA11.72
EV / EBIT12.40
Revenue, mln3,154
EV / Revenue6.23

Financial Strength

Altman Z-Score20.14
Piotroski F-Score 5 / 9
Beneish M-Score-3.07
Price to Intrinsic Value1.41
Price to Lynch Fair Value0.80
Price to Graham Number1.73
1-Year Target Price653
Shiller PE Ratio31.16
Short Ratio3.81
Short % of Float5.76

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.93% 11 / 100   
1 Month -4.73% 22 / 100   
2 Months -15.1% 22 / 100   
6 Months 6.47% 59 / 100   
1 Year 68.1% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us